• Sonuç bulunamadı

Di-peptidyl peptidase-4 inhibitor sitagliptin protects vascular function in metabolic syndrome: possible role of epigenetic regulation (vol 41, pg 4853, 2014)

N/A
N/A
Info
İndir
Protected

Academic year: 2021

Share "Di-peptidyl peptidase-4 inhibitor sitagliptin protects vascular function in metabolic syndrome: possible role of epigenetic regulation (vol 41, pg 4853, 2014)"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Şimdi indir ( 1 sayfa )

Tam metin

(1)

E R R A T U M

Erratum to: Di-peptidyl peptidase-4 inhibitor sitagliptin protects

vascular function in metabolic syndrome: possible role

of epigenetic regulation

Figen Amber Cicek

•

Zeynep Tokcaer-Keskin

•

Evren Ozcinar

•

Yusuf Bozkus

•

Kamil Can Akcali

•

Belma Turan

Published online: 13 August 2014

Ó Springer Science+Business Media Dordrecht 2014

Erratum to: Mol Biol Rep

DOI 10.1007/s11033-014-3392-2

The ordering of authors’ first and last names appear correct

in this erratum.

The online version of the original article can be found under

doi:10.1007/s11033-014-3392-2.

F. A. Cicek Z. Tokcaer-Keskin  K. C. Akcali  B. Turan (&) Department of Biophysics, Faculty of Medicine, Ankara University, Ankara, Turkey

e-mail: belma.turan@medicine.ankara.edu.tr E. Ozcinar

Department of Cardiovascular Surgery, Faculty of Medicine, Ankara University, Ankara, Turkey

Y. Bozkus

Department of Endocrinology and Metabolism,

Faculty of Medicine, Baskent University, Ankara, Turkey

123

Mol Biol Rep (2014) 41:6327 DOI 10.1007/s11033-014-3674-8

Referanslar

Şimdi indir ( PDF - 1 sayfa - 93.75 KB )

Benzer Belgeler

The role of epigenetic mechanisms in cancer development

BRCA1 CpG island promoter methylation prevents tumor suppressor gene mRNA synthesis..

The role of uric acid in metabolic syndrome in patients with psoriasis

The salient findings of our study are that metabolic syndrome prevalence and uric acid levels were higher in psoriasis patients compared with those in healthy control group, and

The role of isovolumic acceleration in predicting subclinical right and left ventricular systolic dysfunction in patient with metabolic syndrome

In the comparison of right and left ventricular diastolic function, the tissue Doppler-derived parameters E’, A’, and E’/A’ ratio were significantly impaired in the MetS patients

Relations between microvascular function and aortic stiffness in metabolic syndrome

MetS patients showed impaired response of myocardial blood flow to a cold press or test in by PET analysis (8), indicating the presence of coronary microvascular

Disease of the Sultans: metabolic syndrome in Ottoman dynasty

If 1 of the diagnostic criteria defined by ACE-ACCE (i.e. hypertension, obesity, diabetes mellitus, dyslipid- emia) was present, presence of at least another metabolic syn-

Reversal of doxorubicin-induced vascular dysfunction by resveratrol in rat thoracic aorta: Is there a possible role of nitric oxide synthase inhibition?

On the other hand, the down-regulation of α1A-adrenoceptors by excessive superoxide formation is supposed to be responsible of the attenuated phenylephrine responses by

The prevalence of aspirin resistance in patients with metabolic syndrome

Metabolic syndrome (3.6 fold) and increased levels of fasting blood glucose (1.1 fold), uric acid (2.2 fold), gamma-glutamyl transferase (1 fold), high-sensitivity CRP (1.1

Prevalence of metabolic syndrome in hypothyroid patients under Levothyroxine therapy

Methods: One hundred and eighty-six hypothyroid patients (175 female, 11 male) using levothyroxine treatment were included in the study.. Demographic, anthropometric